SCHEMBL21452924

SCHEMBL21452924

CC(C)C1CC1c1nc(-c2ccc(OC(F)(F)F)cc2)cc(N2CCC(C(N)=O)CC2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCHR1 Q99705 2/20 0.43
▸ SCN9A Q15858 2/20 0.43
▸ RAB9A P51151 3/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ ABL1 P00519 2/20 0.41
▸ ITGB2 P05107 2/20 0.40
▸ ICAM1 P05362 2/20 0.40
▸ ITGAL P20701 2/20 0.40
▸ PDE4A P27815 1/20 0.40
▸ PDE4B Q07343 1/20 0.40
▸ PDE4D Q08499 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ MCHR2 Q969V1 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ SMPD3 Q9NY59 1/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ FFAR4 Q5NUL3 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21433958 0.85 SCN9A (0.48) MCHR1SCN9ARAB9ASMN1; SMN2ABL1
SCHEMBL21434128 0.82 SCN9A (0.48) MCHR1SCN9ARAB9ASMN1; SMN2ABL1
SCHEMBL21433983 0.81 SMN1; SMN2 (0.51) MCHR1SCN9ARAB9ASMN1; SMN2ABL1
SCHEMBL21433915 0.80 SCN9A (0.46) MCHR1SCN9ARAB9ASMN1; SMN2ABL1
SCHEMBL21433972 0.77 ITGB2 (0.54) MCHR1SCN9ARAB9ASMN1; SMN2ABL1
SCHEMBL21452844 0.72 ITGB2 (0.44) SCN9ARAB9ASMN1; SMN2ABL1ITGB2
SCHEMBL21434071 0.72 TDP1 (0.46) MCHR1SCN9ARAB9ASMN1; SMN2ABL1
SCHEMBL2558990 0.71 SMN1; SMN2 (0.75) RAB9ASMN1; SMN2NPC1L3MBTL1
SCHEMBL31381264 0.71 ABL1 (0.67) MCHR1RAB9ASMN1; SMN2ABL1KDM4E
SCHEMBL21434136 0.70 CHRM3 (0.53) MCHR1PDE4APDE4BPDE4DKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019193516-A2 SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-10-10 — — WO disclosed
Send feedback